Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕Nippon India ETF BSE Sensex Next 50 · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaNippon India
NAV₹29.1863₹93.7420
NAV date20 Nov 202620 Nov 2026
History5.4 years7.3 years
Expense ratio0.2%0.3%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
1 month+10.82%+7.69%
3 months+7.43%−0.74%
6 months+14.54%+6.50%
YTD+25.40%+2.53%
1 year+25.57%+2.36%
3 years (CAGR)+22.02%+15.60%
5 years (CAGR)+16.60%+13.15%
10 years (CAGR)——
Since launch+14.02%+17.05%

Risk

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
Volatility15.0%18.5%
Downside volatility9.0%12.2%
Sharpe1.040.49
Sortino1.720.75
Calmar1.330.75
Return / risk1.470.84
Deepest fall−20.98%−38.30%
Days to recover136239
Below its high−1.75%−1.19%

Against benchmark

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
Alpha+0.00%—
Beta1.00—
R²100.0%—
Up capture100.0%—
Down capture100.0%—
Tracking error0.0%—
Information ratio——
Treynor0.14—

Consistency

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
Best 1-year+65.21%+99.69%
Middle 1-year+13.46%+12.83%
Worst 1-year−15.30%−9.67%
1-year periods with a loss25.8%12.2%
Middle 3-year+20.51%+21.20%
Positive months61.1%69.4%
Best day+3.64%+4.88%
Worst day−4.03%−6.38%
Worst 5% day−1.62%−1.81%
Positive days54.4%56.8%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
5-year XIRR+20.60%+13.91%
5-year value₹10,11,738₹8,56,344
3-year XIRR+19.58%+8.22%
1-year XIRR+34.31%+8.32%

Holdings overlap i

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
Nippon India Nifty Pharma ETF—7%
Nippon India ETF BSE Sensex Next 507%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
Divi's Laboratories Limited12.28%4.70%
Lupin Limited4.83%1.85%

Sectors and company size

Nippon India Nifty Pharma ETFNippon India ETF BSE Sensex Next 50
Large companies45.3%57.8%
Mid companies47.1%42.2%
Small companies7.6%—
Top 10 holdings78.6%30.8%
Largest sectorPharmaceuticals & Biotechnology 100%Banks 15%

Search Growth